BZBo Zhou

Bo Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bo Zhou has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Kun Liao

    Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

    8 shared publications
  • Mei Mei

    Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

    8 shared publications
  • Fengning Chuan

    Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

    7 shared publications
  • Rong Li

    Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China, cqmu.edu.cn

    6 shared publications
  • Wenqing Tian

    Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing, 400042 , China

    6 shared publications
  • Xin Ye

    Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China, cqmu.edu.cn

    6 shared publications

Latest Publications

  • Open Access

    Sex‑specific associations between multiple hormone axes and dynapenic obesity in middle‑aged and older patients with type 2 diabetes

    by Di Yu, Qin Ou, Bo Xie, Yinghao Li, Kun Liao, Rong Li, Mei Mei, Bo Zhou

    Accumulating evidence indicates that hormones play a critical role in the pathogenesis of dynapenic obesity (DO), although the precise relationships and underlying mechanisms remain elusive. This study aimed to investigate sex-stratified associations between multiple hormones and prevalence of DO in type 2 diabetes mellitus (T2DM) populations. In this cross-sectional study of 557 T2DM patients, body composition was assessed by dual-energy X-ray absorptiometry, and hormones from pituitary-target gland axes and the vitamin D system were also tested. Moreover, demographic data, nutritional and inflammatory status, comorbidities and diabetic complications were collected. On the basis of sex-specific cutoff values for grip strength and body fat percentage, the participants were categorized into 4 groups: nondynapenic/nonobese (ND/NO), nondynapenic/obese (ND/O), dynapenic/nonobese (D/NO), and DO. Ordinal logistic regression was used to analyze the associations between the progression of low muscle strength and concurrent adipose accumulation and hormonal profiles. Among the enrolled diabetic adults, the incidence rates of DO in males and females were 20.6% and 37.9%, respectively. Compared with ND/NO patients, DO patients typically exhibit advanced age, poorer nutritional status, reduced gait speed and low-grade inflammation. Moreover, the 25 (OH) D level in males with DO was significantly lower than that in the ND/NO group, and even after full adjustment, 25 (OH)D remained significantly inversely associated with DO progression (OR = 0.98, 95% CI: 0.96–1.00, P < .05); however, in females, the serum dehydroepiandrosterone level also decreased (OR = 0.99, 95% CI: 0.99–1.00, P < .05), whereas the parathyroid hormone level increased (OR = 1.01, 95% CI: 1.00–1.02, P < .05) with increasing DO. DO is relatively common in individuals with T2DM and is closely related to aging, nutritional and inflammatory status, and sex-specific hormonal differences.

  • Open Access

    Sodium Danshensu promotes diabetic wound healing by targeting the EGFR-mediated PI3K-AKT pathway: a combined network pharmacology, machine learning, and in vitro approach

    by Peng Ning, Fan Yang, Hongyi Cao, Bo Zhou

    Sodium Danshensu (SDSS) shows potential in treating diabetic wounds (DWs) owing to its antioxidant, anti-inflammatory, and pro-angiogenesis effects. The specific pharmacological mechanisms of SDSS in achieving the above effects were evaluated. The potential targets of SDSS and DWs were obtained from online databases. Interaction networks were constructed using network pharmacology, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed. Combined with machine learning, the biological targets were evaluated and prioritized. A high-glucose-induced human umbilical vein endothelial cell (HUVEC) model was established for in vitro studies. A total of 126 shared targets of SDSS and DWs were selected, and the core targets included EGFR, CASP3, SRC, ESR1, JUN, NFKB1, IGF1R, ESR2, AR, and PPARG. KEGG enrichment analysis revealed significant enrichment of the PI3K-AKT signaling pathway (P < 0.05). Machine learning indicated EGFR as a key target of SDSS in treating DWs. Findings from molecular docking and molecular dynamics simulation confirmed the stable combination of SDSS and EGFR. In vitro experiments indicated that SDSS may activate the PI3K-AKT pathway via EGFR targets, improve the mobility of high-glucose-induced HUVECs, and increase lumen formation (branch number). It promoted catalase production and inhibited the release of malondialdehyde and inflammatory factors including tumor necrosis factor-α and interleukin-6 (all P < 0.05). SDSS activates the PI3K-AKT pathway via EGFR, promotes endothelial cell migration and angiogenesis, and inhibits oxidative stress and the inflammatory response, highlighting its potential in treating DWs.


  • Open Access

    Dynapenic Abdominal Obesity and Cognitive Impairment in Type 2 Diabetic Patients: A Single‐Center Cross‐Sectional Study

    by Yinghao Li, Yan Pi, Xin Ye, Mei Mei, Kun Liao, Fengning Chuan, Rong Li, Bo Zhou

    Background: The relationship between obesity and cognitive dysfunction remains controversial. Dynapenic abdominal obesity (DAO) is characterized by a combination of abdominal obesity and low muscle strength. However, as a unique subtype of obesity, the relationship between DAO and cognitive function in patients with Type 2 diabetes (T2D) is not clear. Materials and Methods: A total of 270 middle‐aged and older T2D patients were included in the study and divided into four groups: dynapenic obesity (DO), nondynapenic obesity (NO), dynapenic nonobesity (DN), and nondynapenic nonobesity (NN). Patient demographics, lifestyle habits, metabolic and inflammatory markers, diabetes‐related characteristics, grip strength (GS), anthropometry, and Montreal Cognitive Assessment (MoCA) scores were recorded. Multiple linear regression was used to analyze the relationships among GS, waist circumference (WC), DAO, and MoCA scores, and multiple logistic regression was used to identify the factors influencing DAO. Results: Compared with NN patients, patients with DO tended to be older and female. These patients had higher insulin resistance indices and inflammatory indicators, lower hemoglobin levels and estimated glomerular filtration rate (eGFR), and a greater burden of diabetes. In addition, the DO group presented lower gait speeds and greater body fat percentage and limb fat mass. More importantly, they had lower MoCA scores. Notably, DAO and lower GS were associated with lower MoCA scores. The following factors influence DAO: age, gait speed, and diabetic retinopathy. Conclusions: Among middle‐aged and older individuals with T2D, DAO is independently associated with cognitive impairment and presents phenotypic features linked to age and diabetes.


  • Dynapenic abdominal obesity: an important hallmark of metabaging in patients with type 2 diabetes

    by Yan Pi, Yinghao Li, Xin Ye, Mei Mei, Kun Liao, Fengning Chuan, Rong Li, Bo Zhou


  • DXA based radiomics scoring: a novel approach for fragility fracture risk assessment in elderly type 2 diabetes patients

    by Fengning Chuan, Mei Mei, Kun Liao, Xin Ye, Yinghao Li, Ying Li, Rong Li, Bo Zhou

    Summary This study develops a DXA-based radiomic model to predict fracture risk in elderly T2DM patients. The model, validated with AUCs up to 0.774, 0.759, and 0.739 for vertebral, hip, and major osteoporotic fractures respectively, offers a potential tool for personalized fracture risk assessment and management in clinical settings. Purpose To develop and validate a novel radiomic model based on dual-energy X-ray absorptiometry (DXA) lumbar spine and hip images for predicting fracture risk in elderly type 2 diabetes mellitus (T2DM) patients. Methods A training cohort of 294 elderly T2DM patients (October 2019 to August 2022) and a validation cohort from the ABCD cohort were utilized. Radiomics features were extracted from baseline DXA images, and a radiomics model was constructed using Cox proportional hazards regression. A user-friendly radiomics score (Radscore) was derived for practical application. Results In the derivation set, 105 (35.7%) patients had radiographically confirmed vertebral fractures. In the validation set with a median 5-year follow-up, 3.2% experienced incident clinical vertebral fracture, 2.4% incident hip fracture, and 7.0% incident major osteoportic fractures (MOFs). Thirteen features were selected to develop the radiomics model. The AUC for predicting radiographically confirmed vertebral fracture in the derivation set was 0.830 (95% CI: 0.783-0.878). In the validation set, AUCs for predicting incident clinical vertebral fractures, hip fractures, and MOFs were 0.774 (95% CI: 0.686-0.862), 0.759 (95% CI: 0.645-0.873), and 0.739 (95% CI: 0.676-0.803), respectively. The Radscore exhibited weak correlations with traditional fracture assessment tools but independently with the diabetes-specific phenotype. It effectively stratified T2DM patients into risk groups with significantly differing fracture incidences. Conclusions This DXA-based Radscore presented in this study offers a robust approach to stratify fracture risk in elderly patients with T2DM. Its potential integration into clinical settings could facilitate personalized management strategies aimed at reducing fracture incidence.

  • Open Access

    ALM adjusted by BMI or weight predicts adverse health outcomes in middle-aged and elderly patients with type 2 diabetes

    by Bo Xie, Bin Liu, Xue Chen, Fengning Chuan, Kun Liao, Mei Mei, Rong Li, Bo Zhou

    The role of skeletal muscle in the prognosis of patients with Type 2 Diabetes Mellitus (T2DM) remains unclear. This study aimed to systematically evaluate the impact of different muscle-mass adjustment standards on adverse health outcomes in middle-aged and elderly T2DM patients. Retrospective cohort study. A total of 1,818 T2DM patients aged 50 years or older were included in this study. The cohort comprised 45.7% females, with a median age of 63 years. Variables closely correlated with total lean mass (TLM) and appendicular lean mass (ALM) were selected as adjustment indicators. The primary composite endpoints were all-cause mortality, cardiovascular disease (CVD), and fragility fractures. Cox proportional hazards models were used to estimate the risk associated with each indicator, and phenotypic characteristics of high-risk patients were evaluated. During a median follow-up of 63 months, 436 patients reached the primary endpoint. ALM/BMI and ALM/weight were negatively correlated with adverse outcomes in both sexes, even after adjusting for confounding factors (males: ALM/BMI (hazard ratio [HR] = 0.998, 95% confidence interval [CI] = 0.996–0.999, P = 0.005) and ALM/weight (HR = 0.924, 95% CI = 0.864–0.987, P = 0.020); females: ALM/BMI (HR = 0.998, 95% CI = 0.996-1.000, P = 0.030) and ALM/weight (HR = 0.917, 95% CI = 0.860–0.978, P = 0.008), respectively). Individuals with lower ALM/BMI and ALM/weight have poorer metabolic status, greater fat accumulation, more complications, and a lower muscle-to-fat ratio. Our findings demonstrate that both ALM/BMI and ALM/weight can predict adverse health outcomes, suggesting their potential as practical, clinically relevant markers for sarcopenia in T2DM.


  • Open Access

    Misdiagnosis and analysis of clinical characteristics in patients with giant cystic pheochromocytoma/paraganglioma

    by Yue Zhang, Bo Zhou

    Introduction Although giant cystic pheochromocytoma and paraganglioma (PPGL) are uncommon, they can be life-threatening when it occurs. Unfortunately, prior case reports have shown that giant cystic PPGLs are highly susceptible to diagnostic errors. Therefore, this study aimed to explore giant cystic PPGLs by comparing them with non-cystic PPGLs, defining the clinical features of the affected patients, and analyzing the characteristics of misdiagnosis and mistreatment associated with PPGLs. The goal is to provide insights for the timely and accurate diagnosis and treatment of giant cystic PPGLs. Methods A total of 170 cases of pheochromocytoma and paraganglioma (PPGL) diagnosed at the First Affiliated Hospital of Chongqing Medical University from April 2011 to April 2020 were confirmed through clinical evaluation, measurement of catecholamine metabolites, imaging studies, or surgical pathology. The patients were classified into two groups based on the maximum tumor diameter and the presence of cystic components. The clinical characteristics of patients in the giant cystic group, including timely diagnosis and instances of misdiagnosis, are summarized. Additionally, the differences in demographics, clinical manifestations, laboratory examinations, imaging features, treatment approaches, and tumor characteristics between the two groups were analyzed. Results Among the 17 patients in the giant cystic group, eight (47.1%) patients were misdiagnosed. The misdiagnosis and mistreatment characteristics of PPGLs were as follows: female (50%); median age, 51 years; normal blood pressure; greater mass effect at onset; larger tumors; median time to diagnosis extension, 180 days; and misdiagnosed disease, which was mainly tumors of adjacent organs, the digestive system, the cardiovascular system, the urinary system, the nervous system, or the endocrine system. The giant cystic group had greater mass effects than did the non-cystic group (P < 0.05). The proportion of patients with the triad of pheochromocytoma (heart palpitations, sweating and headache) and hypertension was lower; however, this difference was not statistically significant. The blood MN (metanephrine) level was greater, and the hemoglobin and blood low-density lipoprotein cholesterol (LDL-cholesterol) levels were lower (P < 0.05). The proportions of patients with tumor calcification and hemorrhagic necrosis were significantly greater (P < 0.05). There was more intraoperative bleeding, more patients who underwent blood transfusions, and a longer postoperative hospital stay; however, the difference was not statistically significant. Conclusion Giant cystic pheochromocytomas and paragangliomas (PPGLs) are rare, and their clinical manifestations are atypical. Additionally, imaging findings can be challenging to identify due to the presence of large space-occupying adjacent organs. As a result, these giant cystic lesions of unknown origin are often misdiagnosed. Early biochemical examination, in conjunction with imaging characteristics, is essential to accurately determine the nature of the tumor and reduce the rate of misdiagnosis.


  • Open Access

    Identifying and Validating Extracellular Matrix-Related Gene CTSH in Diabetic Foot Ulcer Using Bioinformatics and Machine Learning

    by Pei-Yu Wu, Yan-Lin Yu, Wen-Rui Zhao, Bo Zhou

    Background: Diabetic foot ulcer (DFU) is a serious clinical problem with high amputation and mortality rates, yet there is a lack of desirable therapy. While the extracellular matrix (ECM) contributes significantly to wound healing, ECM-related biomarker for DFU is still unknown. The study was designed to identify ECM-related biomarker in DFU using bioinformatics and machine learning and validate it in STZ-induced mice models. Methods: GSE80178 and GSE134431 microarray datasets were fetched from the GEO database, and differentially expressed genes (DEGs) analysis was performed, respectively. By analyzing DEGs and ECM genes, we identified ECM-related DEGs, and functional enrichment analysis was conducted. Subsequently, three machine learning algorithms (LASSO, RF and SVM-RFE) were applied to filter ECM-related DEGs to identify key ECM-related biomarkers. Next, we conducted immune infiltration analysis, GSEA, and correlation analysis to explore the hub gene underlying mechanism. A lncRNA-miRNA-mRNA and drug regulatory network were constructed. Finally, we validated the key ECM-related biomarker in STZ-induced mice models. Results: One hundred and forty-five common DEGs in adult DFU between the two datasets were identified. Taking the intersection of 145 common DEGs and 964 ECM genes, we identified 13 ECM-related DEGs. Thirteen ECM-related DEGs were mainly enriched in pathways associated with tissue remodeling, inflammation and defense against infectious agents. Ultimately, CTSH was identified as the key ECM-related biomarker. CTSH was associated with difference immune cells during the occurrence and development of DFU, and it influenced hedgehog, IL-17 and TNF signaling pathway. Additionally, CTSH expression is correlated with many ECM- and immune-related genes. A lncRNA-miRNA-mRNA and drug regulatory network were constructed with 10 lncRNAs, 2 miRNAs, CTSH and 1 drug. Finally, CTSH was validated as a key biomarker for DFU in animal models. Conclusion: Our study found that CTSH can be used for both diagnostic and prognostic purposes and might be a potential therapeutic target.


  • The Ca∗Cl/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism

    by Yanling Yu, Jingwen Qiu, Fengning Chuan, Zhengping Feng, Jian Long, Bo Zhou


  • A simple fragility fracture risk score for type 2 diabetes patients: a derivation, validation, comparison, and risk stratification study

    by Fengning Chuan, Youyuan Gao, Kun Liao, Xin Ye, Mei Mei, Wenqing Tian, Rong Li, Bo Zhou

    Objectives: The aims of this study were to develop and validate 2 simple scores for stratification of the risks of (1) any fragility (AF) and (2) major osteoporotic fracture (MOF) in type 2 diabetes (T2D) patients; we also compared the performance of these scores with that of the Fracture Risk Assessment Tool (FRAX) and its adjustments. Design and methods: In this longitudinal cohort study, 1855 patients with T2D were enrolled from January 2015 to August 2019. Cox proportional hazard regression was used to model the 5-year risk of AF and MOF. These scores were internally validated using a bootstrap resampling method of 1000. Results: During a median follow-up of 5 years, 119 (6.42%) cases of AF and 92 (4.96%) cases of MOFs were identified. Both the concordance index (C-index) and calibration plots indicated improved identification performance using the newly established scores. Furthermore, these scores also showed improved outcomes regarding the decision curve analysis (DCA) and area under the curve (AUC) compared to the widely used FRAX and its derivatives. More importantly, these scores successfully separated T2D patients into risk groups according to significant differences in fracture incidence. Conclusions: These novel scores enable simple and reliable fracture risk stratification in T2D patients. Future work is needed to validate these findings in external cohort(s).